Annual SG&A
$59.88 M
+$11.19 M+22.99%
31 March 2024
Summary:
LakeShore Biopharma annual selling, general & administrative expenses is currently $59.88 million, with the most recent change of +$11.19 million (+22.99%) on 31 March 2024. During the last 3 years, it has risen by +$29.13 million (+94.74%). LSB annual SG&A is now at all-time high.LSB Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$15.80 M
-$43.50 K-0.27%
30 September 2023
Summary:
LakeShore Biopharma quarterly selling, general & administrative expenses is currently $15.80 million, with the most recent change of -$43.50 thousand (-0.27%) on 30 September 2023. LSB quarterly SG&A is now -0.27% below its all-time high of $15.84 million, reached on 30 June 2023.LSB Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$548.71 M
-$45.89 M-9.13%
30 September 2023
Summary:
LakeShore Biopharma TTM selling, general & administrative expenses is currently -$548.71 million, with the most recent change of -$45.89 million (-9.13%) on 30 September 2023. LSB TTM SG&A is now -119.33% below its all-time high of $31.63 million, reached on 30 September 2023.LSB TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.0% | - | - |
| 3 y3 years | +94.7% | - | - |
| 5 y5 years | - | - | - |
LSB Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +94.7% | -0.3% | +8.8% | -119.3% | at low |
| 5 y | 5 years | at high | +94.7% | -0.3% | +8.8% | -119.3% | at low |
| alltime | all time | at high | +94.7% | -0.3% | +8.8% | -119.3% | at low |
LakeShore Biopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $59.88 M(+23.0%) | - | - |
| Sept 2023 | - | $15.80 M(-0.3%) | $31.63 M(+2.1%) |
| June 2023 | - | $15.84 M(+4.5%) | $30.99 M(+4.4%) |
| Mar 2023 | $48.69 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $15.15 M(+4.4%) | $29.68 M(+104.4%) |
| June 2022 | - | $14.52 M | $14.52 M |
| Mar 2022 | $42.46 M(+38.1%) | - | - |
| Mar 2021 | $30.75 M | - | - |
FAQ
- What is LakeShore Biopharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for LakeShore Biopharma?
- What is LakeShore Biopharma annual SG&A year-on-year change?
- What is LakeShore Biopharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for LakeShore Biopharma?
- What is LakeShore Biopharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for LakeShore Biopharma?
What is LakeShore Biopharma annual selling, general & administrative expenses?
The current annual SG&A of LSB is $59.88 M
What is the all time high annual SG&A for LakeShore Biopharma?
LakeShore Biopharma all-time high annual selling, general & administrative expenses is $59.88 M
What is LakeShore Biopharma annual SG&A year-on-year change?
Over the past year, LSB annual selling, general & administrative expenses has changed by +$11.19 M (+22.99%)
What is LakeShore Biopharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of LSB is $15.80 M
What is the all time high quarterly SG&A for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly selling, general & administrative expenses is $15.84 M
What is LakeShore Biopharma TTM selling, general & administrative expenses?
The current TTM SG&A of LSB is -$548.71 M
What is the all time high TTM SG&A for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM selling, general & administrative expenses is $31.63 M